These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12875295)

  • 1. Case report: Rectal adminstration of ivermectin to a patient with Strongyloides hyperinfection syndrome.
    Tarr PE; Miele PS; Peregoy KS; Smith MA; Neva FA; Lucey DR
    Am J Trop Med Hyg; 2003 Apr; 68(4):453-5. PubMed ID: 12875295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of ivermectin per rectum to achieve clinically meaningful serum levels in two cases of Strongyloides hyperinfection.
    Bogoch II; Khan K; Abrams H; Nott C; Leung E; Fleckenstein L; Keystone JS
    Am J Trop Med Hyg; 2015 Jul; 93(1):94-6. PubMed ID: 25918215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report.
    Pacanowski J; Santos MD; Roux A; LE Maignan C; Guillot J; Lavarde V; Cornet M
    Am J Trop Med Hyg; 2005 Jul; 73(1):122-4. PubMed ID: 16014846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum ivermectin levels after enteral and subcutaneous administration for Strongyloides hyperinfection: a case report.
    Grein JD; Mathisen GE; Donovan S; Fleckenstein L
    Scand J Infect Dis; 2010 Mar; 42(3):234-6. PubMed ID: 20085425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin.
    Lichtenberger P; Rosa-Cunha I; Morris M; Nishida S; Akpinar E; Gaitan J; Tzakis A; Doblecki-Lewis S
    Transpl Infect Dis; 2009 Apr; 11(2):137-42. PubMed ID: 19144097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis.
    Turner SA; Maclean JD; Fleckenstein L; Greenaway C
    Am J Trop Med Hyg; 2005 Nov; 73(5):911-4. PubMed ID: 16282302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report: failure of subcutaneous ivermectin in treating Strongyloides hyperinfection.
    Leung V; Al-Rawahi GN; Grant J; Fleckenstein L; Bowie W
    Am J Trop Med Hyg; 2008 Dec; 79(6):853-5. PubMed ID: 19052292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful use of subcutaneous ivermectin for the treatment of
    Zeitler K; Jariwala R; Restrepo-Jaramillo R; Kapadia S; Casanas B; Alrabaa S; Sriaroon C
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29866667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin.
    Hauber HP; Galle J; Chiodini PL; Rupp J; Birke R; Vollmer E; Zabel P; Lange C
    Infection; 2005 Oct; 33(5-6):383-6. PubMed ID: 16258873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis.
    Suputtamongkol Y; Kungpanichkul N; Silpasakorn S; Beeching NJ
    Int J Antimicrob Agents; 2008 Jan; 31(1):46-9. PubMed ID: 18023151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage treatment of disseminated strongyloidiasis in an immunocompromised patient: therapy success with subcutaneous ivermectin.
    Moura EB; Maia Mde O; Ghazi M; Amorim FF; Pinhati HM
    Braz J Infect Dis; 2012; 16(5):479-81. PubMed ID: 22975175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strongyloides hyperinfection syndrome complications: a case report and review of the literature.
    Najmuddin A; Hadique S; Parker J
    W V Med J; 2012; 108(1):32-8. PubMed ID: 25134190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of Strongyloides stercoralis hyperinfection in a case of systemic lupus erythematosus - review of the literature regarding various treatment schedules.
    Mohanasundaram K; Rajasekaran K; Selvaraj J; Balasubramanian A
    Trop Doct; 2012 Oct; 42(4):223-5. PubMed ID: 22875806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan.
    Toma H; Sato Y; Shiroma Y; Kobayashi J; Shimabukuro I; Takara M
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):147-51. PubMed ID: 11023084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for strongyloidiasis hyperinfection and clinical outcomes.
    Asdamongkol N; Pornsuriyasak P; Sungkanuparph S
    Southeast Asian J Trop Med Public Health; 2006 Sep; 37(5):875-84. PubMed ID: 17333728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection.
    Segarra-Newnham M
    Ann Pharmacother; 2007 Dec; 41(12):1992-2001. PubMed ID: 17940124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of autochotonous anguilluliasis].
    Magnaval JF
    Med Trop (Mars); 1999; 59(3):310. PubMed ID: 10701217
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin.
    Marty FM; Lowry CM; Rodriguez M; Milner DA; Pieciak WS; Sinha A; Fleckenstein L; Baden LR
    Clin Infect Dis; 2005 Jul; 41(1):e5-8. PubMed ID: 15937753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous ivermectin for the treatment of the hyperinfection syndrome by Strongyloides stercoralis.
    Hennessey DC; Ballesteros ÓA; Merchán DJ; Guevara FO; Severiche DF
    Biomedica; 2020 Jun; 40(2):228-232. PubMed ID: 32673452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strongyloides hyperinfection syndrome after intestinal transplantation.
    Patel G; Arvelakis A; Sauter BV; Gondolesi GE; Caplivski D; Huprikar S
    Transpl Infect Dis; 2008 Apr; 10(2):137-41. PubMed ID: 17605735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.